AZD1656

glucokinase ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34853102 ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19. 2021 Dec 1 1
2 23464532 Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin. 2013 Aug 2
3 23522182 Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus. 2013 Oct 2
4 22943931 Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clamp. 2012 Nov 3